WallStSmart
PM

Philip Morris International Inc

NYSE: PM · CONSUMER DEFENSIVE · TOBACCO

$165.07
+1.45% today

Updated 2026-04-29

Market cap
$255.91B
P/E ratio
23.09
P/S ratio
6.17x
EPS (TTM)
$7.11
Dividend yield
3.40%
52W range
$140 – $190
Volume
4.9M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Philip Morris International Inc (PM) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current
$165.07
Consensus
$189.78
+14.97%
2030 Target
$426.87
+158.60%
DCF
$115.38
-41.06% MoS
9 analysts:
3 Buy2 Hold0 Sell

Management guidance

Philip Morris management has guided for currency-neutral organic growth in 2026 while raising full-year adjusted diluted EPS guidance to $8.36-$8.51 (10.9-12.9% growth). Management emphasized strong smoke-free product momentum (IQOS, ZYN, VEEV) representing 43% of net revenues in Q1 2026, with continued international strength offsetting U.S. ZYN inventory normalization. No specific multi-year revenue targets (2027-2030) were disclosed in available guidance.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range
Bull case (2030)
$711.45
$55.6B Rev × 20x P/S
Base case (2030)
$426.87
$55.6B Rev × 12x P/S
Bear case (2030)
$284.58
$55.6B Rev × 8x P/S

Financial forecast — research-backed

Metric2023202420252026 (E)2027 (E)2028 (E)2029 (E)2030 (E)
Revenue$35.2B$37.9B$40.6B$44.9B$47.9B$51.2B$53.3B$55.6B
Revenue growth—7.7%7.3%10.5%6.7%6.8%5.0%4.3%
EPS$6.01$6.55$7.54$8.71$9.48$10.35$10.85$11.45
P/S ratio———4.0x4.0x4.0x12.0x12.0x
Implied price———$112.63$112.63$128.72$411.06$426.87

Catalysts & risks

Growth catalysts
+ FDA reauthorization of IQOS as Modified Risk Tobacco Product (April 2026) validating smoke-free transition strategy
+ ZYN nicotine pouch market expansion and competitive positioning against Altria's on! PLUS
+ International smoke-free product penetration acceleration in key markets (EU, Asia, LATAM)
+ Margin expansion from high-margin smoke-free product mix shift (43% of revenues, higher margins than combustibles)
+ Strategic partnerships (Ducati Corse MotoGP sponsorship) driving brand engagement with adult consumers
Key risks
- U.S. ZYN market inventory normalization and competitive intensity limiting growth acceleration
- Regulatory headwinds: potential excise tax increases, nicotine pouch restrictions, and modified risk claims challenges
- Currency headwinds impacting reported revenues (management guiding for currency-neutral growth only)
- Illicit tobacco market (reported as 1-in-3 cigarettes in Americas), eroding volume and pricing power
- Declining traditional combustible cigarette volumes may not be fully offset by smoke-free transition speed

Methodology

Philip Morris International Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 9 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 28, 2026.